Daniel Kraft
Stanford and Harvard-trained physician-scientist, inventor, entrepreneur, and innovator
Daniel Kraft is a Stanford and Harvard-trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has served as faculty chair for Medicine at Singularity University since its inception in 2008, and in 2011 founded NextMed Health (previously called Exponential Medicine) a program and community that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare. He serves as Chair of the XPRIZE Pandemic & Health Alliance.
Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology, and bone marrow transplantation at Stanford.
Daniel is a member of the Inaugural class of the Aspen Institute Health Innovators Fellowship and is member of the Kauffman Fellows Society. He is a managing partner with Continuum Health Ventures which is focused on funding early stage health tech companies enabling the democratization of health and improved healthspan for all.
He is often called upon to speak to the future of health, medicine and technology and has given four TED and two TEDMED Talks and has delivered keynotes to a diverse array of organizations.
He has multiple scientific publications (including in Nature and Science) and medical device, immunology, and stem cell-related patents through NIH-funded faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at the University of California San Francisco.
Daniel's academic research has focused on: stem cell biology and regenerative medicine, stem cell-derived immunotherapies for cancer, bioengineering human T-cell differentiation, and humanized animal models. His research has been published in journals that include Nature and Science. His clinical work has focused on: bone marrow & hematopoietic stem cell transplantation for malignant and non-malignant diseases in adults and children, medical devices to enable stem cell based regenerative medicine.
He is heavily involved in digital health, founded Digital.Health, is on the board of Healthy.io and advises several Fortune-50 and digital health-related startups. Daniel recently founded IntelliMedicine, focused on personalized, data-driven, precision medicine. He is also the inventor of the MarrowMiner, an FDA-approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell-based regenerative therapies.
Daniel is an avid pilot and has served in the Massachusetts and California Air National Guard as an officer and flight surgeonwith F-15 & F-16 fighter Squadrons. He has conducted research on aerospace medicine that was published with NASA, with whom he was a finalist for astronaut selection.
EDUCATION:
- Bachelor of Arts in Biochemistry, Brown University
- Medical Doctor, Stanford University School of Medicine
- Residency: Harvard Combined Residency in Internal Medicine & Pediatrics
- Fellowships: Stanford Hematology/Oncology & Bone Marrow Transplantation
Aspen Institute Health Innovators Fellow: Member of Inaugural class.
